Showing 1 - 7 results of 7 for search '"молекулярная цитогенетика"', query time: 0.47s Refine Results
  1. 1
    Academic Journal

    Source: Fundamental and applied research for key propriety areas of bioecology and biotechnology; 56-68 ; Фундаментальные и прикладные исследования по приоритетным направлениям биоэкологии и биотехнологии; 56-68

    File Description: text/html

    Relation: info:eu-repo/semantics/altIdentifier/isbn/978-5-907965-64-5; https://phsreda.com/e-articles/10716/Action10716-139064.pdf; Нугиc В.Ю. FISH-метод: способ цитогенетической ретроспективной оценки дозы (обзор) / В.Ю. Нугис // Саратовский научно-медицинский журнал. – 2016. – №12 (4). – С. 671–678. EDN YPYFKV; Bishop R. Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significance // Bioscience Horizons: The International Journal of Student Research. 2010. Vol. 3. №1. Pp. 85–95.; Boyd C., Boyle D. Molecular diagnosis on tissues and cells: how it affects training and will affect practice in the future // Cytopathology. 2012. №23 (5). – Pp. 286–294.; Carter D. How fluorescence in situ hybridization (FISH) fits into cancer care The University of Texas MD Anderson Cancer Center // The University of Texas MD Anderson Cancer Center. 2021.; Casaluce F., Sgambato A., Maione P. [et al.]. C. ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC // Target Oncol. 2013. №8 (1). Pp. 55–67. DOI 10.1007/s11523-012-0250-9. EDN UMBEYJ; Casper R.M., Leonard K., Mpho M., Bono N. Recent Molecular Techniques in Cytogenetics. 2025.; Chen J., Shi Q., Zhang J. [et al.]. Detection of mosaic chromosome 21 aneuploidy in vivo with CB-FISH method // Chinese journal of medical genetics. 2000. Vol. 17 (3). Pp. 196–199.; Chudova I. Fluorescence in situ hybridization. In: Chromosomal alterations: methods, results and importance in human’s health. Berlin, Heidelberg, New York: Springer-Verlag. 2007. Pp. 285–299.; Cytogenetic dosimetry: applications in preparedness for and response to radiation emergencies // Vienna: IAEA. 2011. P. 229.; de Barros A.V., Sczepanski Th.S., Cabrero J., Artoni R.F. Fiber FISH reveals different patterns of highresolution physical mapping for repetitive DNA in fish. // Aquaculture. 2018. Vol. 322. Pp. 47–50.; Dhabe A., Islam R., Ramakrishnan K., Parihar M. Role of Cytogenetics and FISH in laboratory workup of B cell precursor acute lymphoblastic leukemia // Indian J Med Paediatr Oncol. 2023. №44 (05). Pp. 482–493. DOI 10.1055/s-0043-1766133. EDN VXODKF; Dietel M., Johrens K., Laffert M. [et al.]. Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance // Cancer Gene Ther. 2013. №20 (4). Pp. 211–221.; Eckel H., Kleinstein J., Wieacker P., Stumm M. Multi-locus (ML)-FISH is a reliable tool for nondisjunction studies in human oocytes // Cytogenet. Genome. 2003. №103. Pp. 47–53.; Gandhi L., Janne P. Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target // Clin Cancer Res. 2012. Vol. 18 (14). Pp. 3737–3742.; Hu L., Ru K., Zhang L. [et al.]. Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine // Biomarker Research. 2014. Vol. 2. DOI 10.1186/2050-7771-2-3. EDN EEHUMZ; Jiang H., Xue Y., Wang Q. [et al.]. The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure // Leuk Res. 2012. №36 (4). Pp. 448–452.; Khalaf S.D., Alhamadany A.Y., Kader M.A. Fluorescence in situ hybridization (FISH): types and application: a review // NTU Journal of Pure Sceinces. 2023. №2 (2). Pp. 37–53.; Kim H., Lim S., Kim H. [et al.]. The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma // Ann Oncol. 2013. №24 (9). Pp. 2364–2370.; Landau D., Wu C. Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics // Genome Med. 2013. №5 (5):47.; Pathmanathan N., Bilous A. HER2 testing in breast cancer: an overview of current techniques and recent developments // Pathology. 2012. №44 (7). Pp. 587–595.; Rubtsov N. Hybridization of nucleic acids in situ in the analysis of chromosomal abnormalities. In: Moleculargenetic methods in diagnostics of hereditary diseases and cancer. Introduction to molecular diagnostics // Moscow: Meditsina. – 2011. Vol. 2. Pp. 100–136.; Savage J., Simpson P. On the scoring of FISH- «painting» chromosome-type exchange aberrations // Mutat Res. 1994. №307 (1). Pp. 345–353.; Shakoori AR. Fluorescence In Situ Hybridization (FISH) and Its Applications // Chromosome Structure and Aberrations. 2017. №10. Pp. 343–367.; Song J., Mooi WJ., Petronic-Rosic V. [et al.]. Nevus versus melanoma: to FISH, or not to FISH // Adv Anat Pathol. 2011. №18. Pp. 229–234.; Stanley J., Hui H., Erber W. [et al.]. Analysis of human chromosomes by imaging flow cytometry. Cytometry Part B // Clinical Cytometry. 2021. №100 (5). Pp. 541–553.; Tanke H.J., Wiegant J., van Gijlswijk R. [et al.]. New strategy for multi-colour fluorescence in situ hybridisation: COBRA: combined binary ratio labelling // Eur. J. Hum. Genet. 1999. №7. Pp. 2–11.; Tubbs R., Pettay J., Roche P. [et al.]. Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH): a fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression // J. Mol. Diagn. 2000. №2. Pp. 78–83.; Tucker J., Morgan W., Awa A. [et al.]. A proposed system for scoring structural aberrations detected by chromosome painting // Cytogenet Cell Genet. 1995. №68 (3–4). Pp. 211–221.; Volpi E.V., Bridger J.M. FISH glossary: an overview of the fluorescence in situ hybridization technique. 2018.; Volpi E.V., Bridger J.M. FISH glossary: an overview of the fluorescence in situ hybridization technique // BioTechniques. 2008. №45. Pp. 385–409. DOI 10.2144/000112811. EDN MMGAIL; Wertheim G., Hexner E., Bagg A. Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations // Mol Diagn Ther. 2012. №16 (6). Pp. 357–369.; Wolff D., Bagg A., Cooley L. [et al.]. Guidance for Fluorescence in situ Hybridization Testing in Hematologic Disorders // SPECIAL ARTICLE. 2007. Vol. 9. №2. Pp. 134–143.; https://phsreda.com/article/139064/discussion_platform

  2. 2
  3. 3
    Academic Journal

    Source: Problems of Environmental Biotechnology; No. 1 (2012) ; Проблемы экологической биотехнологии; № 1 (2012) ; Проблеми екологічної біотехнології; № 1 (2012) ; 2306-6407

    File Description: application/pdf

  4. 4
  5. 5
  6. 6
  7. 7